Nano X Imaging Ltd (NNOX)
8.96
+0.04
(+0.45%)
USD |
NASDAQ |
Apr 26, 16:00
8.92
-0.04
(-0.45%)
Pre-Market: 08:00
Nano X Imaging Total Liabilities (Quarterly): 23.13M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 23.13M |
| September 30, 2023 | 29.28M |
| June 30, 2023 | 31.35M |
| March 31, 2023 | 32.24M |
| December 31, 2022 | 37.25M |
| September 30, 2022 | 57.85M |
| June 30, 2022 | 55.45M |
| March 31, 2022 | 70.21M |
| Date | Value |
|---|---|
| December 31, 2021 | 71.02M |
| September 30, 2021 | 9.927M |
| June 30, 2021 | 6.223M |
| March 31, 2021 | 19.28M |
| December 31, 2020 | 5.403M |
| September 30, 2020 | 6.563M |
| June 30, 2020 | 3.222M |
| December 31, 2019 | 20.65M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
3.222M
Minimum
Jun 2020
71.02M
Maximum
Dec 2021
29.94M
Average
26.21M
Median
Total Liabilities (Quarterly) Benchmarks
| Recursion Pharmaceuticals Inc | 190.26M |
| InMode Ltd | 75.91M |
| Inspira Technologies Oxy BHN Ltd | 3.288M |
| SciSparc Ltd | 1.595M |
| Can Fite Biofarma Ltd | 3.746M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 218.65M |
| Shareholders Equity (Quarterly) | 195.51M |
| Debt to Equity Ratio | 0.0179 |
| Current Ratio | 5.710 |
| Net Debt Paydown Yield | 0.01% |